Robert F Friel insider trades

Open-market stock purchases and sales by Robert F Friel, Director at Xylem Inc, from SEC Form 4 filings since Jan 5, 2010.

Recent trades

DateStockTradeValue
May 14, 2026XYL Xylem IncBought (not open market)$290K
May 4, 2026WST West Pharmaceutical Services IncBought (not open market)—

Companies traded

  • XYL Xylem Inc: other filings, last May 14, 2026
  • WST West Pharmaceutical Services Inc: other filings, last May 4, 2026
  • NUVA Nuvasive Inc: other filings, last Sep 1, 2023
  • PKI Perkinelmer Inc: 29 sales, last Oct 1, 2018
  • CFN CAREFUSION Corp: other filings, last Mar 17, 2015

Get free alerts when Robert F Friel files a new trade →